AKT1 and stroke disorder: Genistein treatment blocked targeting estrogen, nuclear factor (NF)-kappa B, direct antioxidant action, androgen-mediated molecular, and Akt signaling pathways which are important for stroke damages decreasing and cell survival increasing [34].